Gene Ontology terms associated with a binding site
- Binding site
- Motif_474
- Name
- ELRENTCHN50
- Description
- Elicitor-responsive element (ElRE); Found in tobacco basic class I chitinase gene (CHN50)
- #Associated genes
- 30
- #Associated GO terms
- 348
Biological Process
Molecular Function
Cellular Component
Cellular Component (back to top)
Click table-header(s) to enable sortingGO | Description | #Associated genes | ath | bra | cme | egr | gma | ptr | ppe | sly | stu | vvi |
---|---|---|---|---|---|---|---|---|---|---|---|---|
GO:0005623 | cell | 14 (46.67%) | 1 | 1 | 0 | 2 | 2 | 3 | 3 | 0 | 0 | 2 |
GO:0044464 | cell part | 14 (46.67%) | 1 | 1 | 0 | 2 | 2 | 3 | 3 | 0 | 0 | 2 |
GO:0005622 | intracellular | 12 (40.00%) | 1 | 0 | 0 | 2 | 2 | 3 | 2 | 0 | 0 | 2 |
GO:0044424 | intracellular part | 12 (40.00%) | 1 | 0 | 0 | 2 | 2 | 3 | 2 | 0 | 0 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 10 (33.33%) | 1 | 0 | 0 | 1 | 2 | 2 | 2 | 0 | 0 | 2 |
GO:0043229 | intracellular organelle | 10 (33.33%) | 1 | 0 | 0 | 1 | 2 | 2 | 2 | 0 | 0 | 2 |
GO:0043227 | membrane-bounded organelle | 10 (33.33%) | 1 | 0 | 0 | 1 | 2 | 2 | 2 | 0 | 0 | 2 |
GO:0043226 | organelle | 10 (33.33%) | 1 | 0 | 0 | 1 | 2 | 2 | 2 | 0 | 0 | 2 |
GO:0005634 | nucleus | 9 (30.00%) | 1 | 0 | 0 | 1 | 2 | 1 | 2 | 0 | 0 | 2 |
GO:0005737 | cytoplasm | 7 (23.33%) | 0 | 0 | 0 | 2 | 0 | 2 | 1 | 0 | 0 | 2 |
GO:0071944 | cell periphery | 3 (10.00%) | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 |
GO:0044444 | cytoplasmic part | 3 (10.00%) | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 1 |
GO:0005829 | cytosol | 2 (6.67%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 |
GO:0016020 | membrane | 2 (6.67%) | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0005886 | plasma membrane | 2 (6.67%) | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0005794 | Golgi apparatus | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:1902494 | catalytic complex | 1 (3.33%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0030054 | cell junction | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0005618 | cell wall | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0005911 | cell-cell junction | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0009898 | cytoplasmic side of plasma membrane | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0005768 | endosome | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0030312 | external encapsulating structure | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0032991 | macromolecular complex | 1 (3.33%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0044425 | membrane part | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0009505 | plant-type cell wall | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0044459 | plasma membrane part | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0009506 | plasmodesma | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0043234 | protein complex | 1 (3.33%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0055044 | symplast | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0005802 | trans-Golgi network | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0000151 | ubiquitin ligase complex | 1 (3.33%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Molecular Function (back to top)
Click table-header(s) to enable sortingGO | Description | #Associated genes | ath | bra | cme | egr | gma | ptr | ppe | sly | stu | vvi |
---|---|---|---|---|---|---|---|---|---|---|---|---|
GO:0005488 | binding | 22 (73.33%) | 1 | 2 | 2 | 3 | 2 | 4 | 4 | 0 | 0 | 4 |
GO:0003824 | catalytic activity | 12 (40.00%) | 1 | 1 | 0 | 4 | 0 | 2 | 3 | 0 | 0 | 1 |
GO:1901363 | heterocyclic compound binding | 12 (40.00%) | 0 | 1 | 0 | 1 | 2 | 2 | 4 | 0 | 0 | 2 |
GO:0097159 | organic cyclic compound binding | 12 (40.00%) | 0 | 1 | 0 | 1 | 2 | 2 | 4 | 0 | 0 | 2 |
GO:0005515 | protein binding | 11 (36.67%) | 1 | 2 | 2 | 2 | 0 | 1 | 1 | 0 | 0 | 2 |
GO:0003677 | DNA binding | 7 (23.33%) | 0 | 0 | 0 | 1 | 2 | 1 | 2 | 0 | 0 | 1 |
GO:0003676 | nucleic acid binding | 7 (23.33%) | 0 | 0 | 0 | 1 | 2 | 1 | 2 | 0 | 0 | 1 |
GO:0043167 | ion binding | 6 (20.00%) | 0 | 1 | 0 | 0 | 0 | 2 | 2 | 0 | 0 | 1 |
GO:0016740 | transferase activity | 6 (20.00%) | 0 | 1 | 0 | 0 | 0 | 1 | 3 | 0 | 0 | 1 |
GO:0005524 | ATP binding | 5 (16.67%) | 0 | 1 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 1 |
GO:0030554 | adenyl nucleotide binding | 5 (16.67%) | 0 | 1 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 1 |
GO:0032559 | adenyl ribonucleotide binding | 5 (16.67%) | 0 | 1 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 1 |
GO:0043168 | anion binding | 5 (16.67%) | 0 | 1 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 1 |
GO:0097367 | carbohydrate derivative binding | 5 (16.67%) | 0 | 1 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 1 |
GO:0016301 | kinase activity | 5 (16.67%) | 0 | 1 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 1 |
GO:0001882 | nucleoside binding | 5 (16.67%) | 0 | 1 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 1 |
GO:1901265 | nucleoside phosphate binding | 5 (16.67%) | 0 | 1 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 1 |
GO:0000166 | nucleotide binding | 5 (16.67%) | 0 | 1 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 1 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 5 (16.67%) | 0 | 1 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 1 |
GO:0004672 | protein kinase activity | 5 (16.67%) | 0 | 1 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 1 |
GO:0001883 | purine nucleoside binding | 5 (16.67%) | 0 | 1 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 1 |
GO:0017076 | purine nucleotide binding | 5 (16.67%) | 0 | 1 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 1 |
GO:0032550 | purine ribonucleoside binding | 5 (16.67%) | 0 | 1 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 1 |
GO:0035639 | purine ribonucleoside triphosphate binding | 5 (16.67%) | 0 | 1 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 1 |
GO:0032555 | purine ribonucleotide binding | 5 (16.67%) | 0 | 1 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 1 |
GO:0032549 | ribonucleoside binding | 5 (16.67%) | 0 | 1 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 1 |
GO:0032553 | ribonucleotide binding | 5 (16.67%) | 0 | 1 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 1 |
GO:0036094 | small molecule binding | 5 (16.67%) | 0 | 1 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 1 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 5 (16.67%) | 0 | 1 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 1 |
GO:0003682 | chromatin binding | 3 (10.00%) | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 0 |
GO:0001071 | nucleic acid binding transcription factor activity | 3 (10.00%) | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 1 |
GO:0016491 | oxidoreductase activity | 3 (10.00%) | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0046983 | protein dimerization activity | 3 (10.00%) | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 |
GO:0004674 | protein serine/threonine kinase activity | 3 (10.00%) | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 3 (10.00%) | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 1 |
GO:0051213 | dioxygenase activity | 2 (6.67%) | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0016787 | hydrolase activity | 2 (6.67%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0016788 | hydrolase activity, acting on ester bonds | 2 (6.67%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0008289 | lipid binding | 2 (6.67%) | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 |
GO:0060089 | molecular transducer activity | 2 (6.67%) | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 2 (6.67%) | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors | 2 (6.67%) | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0043565 | sequence-specific DNA binding | 2 (6.67%) | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 |
GO:0004871 | signal transducer activity | 2 (6.67%) | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0005092 | GDP-dissociation inhibitor activity | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0051020 | GTPase binding | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0030695 | GTPase regulator activity | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0008536 | Ran GTPase binding | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0017016 | Ras GTPase binding | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0005094 | Rho GDP-dissociation inhibitor activity | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0003993 | acid phosphatase activity | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0016881 | acid-amino acid ligase activity | 1 (3.33%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0052689 | carboxylic ester hydrolase activity | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0043169 | cation binding | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0019899 | enzyme binding | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0030234 | enzyme regulator activity | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0016874 | ligase activity | 1 (3.33%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0016879 | ligase activity, forming carbon-nitrogen bonds | 1 (3.33%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0016298 | lipase activity | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0046872 | metal ion binding | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0060589 | nucleoside-triphosphatase regulator activity | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0016791 | phosphatase activity | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0042578 | phosphoric ester hydrolase activity | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0031267 | small GTPase binding | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0005083 | small GTPase regulator activity | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0019787 | small conjugating protein ligase activity | 1 (3.33%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0016757 | transferase activity, transferring glycosyl groups | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0016758 | transferase activity, transferring hexosyl groups | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0004806 | triglyceride lipase activity | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0004842 | ubiquitin-protein ligase activity | 1 (3.33%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Biological Process (back to top)
Click table-header(s) to enable sortingGO | Description | #Associated genes | ath | bra | cme | egr | gma | ptr | ppe | sly | stu | vvi |
---|---|---|---|---|---|---|---|---|---|---|---|---|
GO:0008152 | metabolic process | 18 (60.00%) | 1 | 1 | 0 | 4 | 2 | 2 | 4 | 0 | 0 | 4 |
GO:0009987 | cellular process | 16 (53.33%) | 1 | 1 | 0 | 2 | 2 | 3 | 3 | 0 | 0 | 4 |
GO:0071704 | organic substance metabolic process | 14 (46.67%) | 1 | 1 | 0 | 1 | 2 | 2 | 3 | 0 | 0 | 4 |
GO:0044237 | cellular metabolic process | 13 (43.33%) | 1 | 1 | 0 | 1 | 2 | 2 | 3 | 0 | 0 | 3 |
GO:0043170 | macromolecule metabolic process | 13 (43.33%) | 1 | 1 | 0 | 0 | 2 | 2 | 3 | 0 | 0 | 4 |
GO:0044238 | primary metabolic process | 13 (43.33%) | 1 | 1 | 0 | 1 | 2 | 2 | 3 | 0 | 0 | 3 |
GO:0044260 | cellular macromolecule metabolic process | 12 (40.00%) | 1 | 1 | 0 | 0 | 2 | 2 | 3 | 0 | 0 | 3 |
GO:0065007 | biological regulation | 9 (30.00%) | 0 | 0 | 0 | 1 | 2 | 1 | 2 | 0 | 0 | 3 |
GO:0050789 | regulation of biological process | 9 (30.00%) | 0 | 0 | 0 | 1 | 2 | 1 | 2 | 0 | 0 | 3 |
GO:0044699 | single-organism process | 9 (30.00%) | 0 | 0 | 0 | 5 | 0 | 2 | 1 | 0 | 0 | 1 |
GO:0050794 | regulation of cellular process | 8 (26.67%) | 0 | 0 | 0 | 1 | 2 | 1 | 2 | 0 | 0 | 2 |
GO:0019222 | regulation of metabolic process | 8 (26.67%) | 0 | 0 | 0 | 1 | 2 | 1 | 1 | 0 | 0 | 3 |
GO:0010467 | gene expression | 7 (23.33%) | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 3 |
GO:0031323 | regulation of cellular metabolic process | 7 (23.33%) | 0 | 0 | 0 | 1 | 2 | 1 | 1 | 0 | 0 | 2 |
GO:0010468 | regulation of gene expression | 7 (23.33%) | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 3 |
GO:0060255 | regulation of macromolecule metabolic process | 7 (23.33%) | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 3 |
GO:0032774 | RNA biosynthetic process | 6 (20.00%) | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 2 |
GO:0016070 | RNA metabolic process | 6 (20.00%) | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 2 |
GO:0019438 | aromatic compound biosynthetic process | 6 (20.00%) | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 2 |
GO:0009058 | biosynthetic process | 6 (20.00%) | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 2 |
GO:0006725 | cellular aromatic compound metabolic process | 6 (20.00%) | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 2 |
GO:0044249 | cellular biosynthetic process | 6 (20.00%) | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 2 |
GO:0034645 | cellular macromolecule biosynthetic process | 6 (20.00%) | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 2 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 6 (20.00%) | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 2 |
GO:0034641 | cellular nitrogen compound metabolic process | 6 (20.00%) | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 2 |
GO:0044267 | cellular protein metabolic process | 6 (20.00%) | 1 | 1 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 1 |
GO:0006464 | cellular protein modification process | 6 (20.00%) | 1 | 1 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 1 |
GO:0018130 | heterocycle biosynthetic process | 6 (20.00%) | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 2 |
GO:0046483 | heterocycle metabolic process | 6 (20.00%) | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 2 |
GO:0009059 | macromolecule biosynthetic process | 6 (20.00%) | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 2 |
GO:0043412 | macromolecule modification | 6 (20.00%) | 1 | 1 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 1 |
GO:0006807 | nitrogen compound metabolic process | 6 (20.00%) | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 2 |
GO:0090304 | nucleic acid metabolic process | 6 (20.00%) | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 2 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 6 (20.00%) | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 2 |
GO:0006139 | nucleobase-containing compound metabolic process | 6 (20.00%) | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 2 |
GO:1901362 | organic cyclic compound biosynthetic process | 6 (20.00%) | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 2 |
GO:1901360 | organic cyclic compound metabolic process | 6 (20.00%) | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 2 |
GO:1901576 | organic substance biosynthetic process | 6 (20.00%) | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 2 |
GO:0019538 | protein metabolic process | 6 (20.00%) | 1 | 1 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 1 |
GO:0036211 | protein modification process | 6 (20.00%) | 1 | 1 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 1 |
GO:2001141 | regulation of RNA biosynthetic process | 6 (20.00%) | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 2 |
GO:0051252 | regulation of RNA metabolic process | 6 (20.00%) | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 2 |
GO:0009889 | regulation of biosynthetic process | 6 (20.00%) | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 2 |
GO:0031326 | regulation of cellular biosynthetic process | 6 (20.00%) | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 2 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 6 (20.00%) | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 2 |
GO:0010556 | regulation of macromolecule biosynthetic process | 6 (20.00%) | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 2 |
GO:0051171 | regulation of nitrogen compound metabolic process | 6 (20.00%) | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 2 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 6 (20.00%) | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 2 |
GO:0080090 | regulation of primary metabolic process | 6 (20.00%) | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 2 |
GO:0006355 | regulation of transcription, DNA-dependent | 6 (20.00%) | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 2 |
GO:0044763 | single-organism cellular process | 6 (20.00%) | 0 | 0 | 0 | 2 | 0 | 2 | 1 | 0 | 0 | 1 |
GO:0006351 | transcription, DNA-templated | 6 (20.00%) | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 2 |
GO:0006796 | phosphate-containing compound metabolic process | 5 (16.67%) | 0 | 1 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 1 |
GO:0006793 | phosphorus metabolic process | 5 (16.67%) | 0 | 1 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 1 |
GO:0016310 | phosphorylation | 5 (16.67%) | 0 | 1 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 1 |
GO:0006468 | protein phosphorylation | 5 (16.67%) | 0 | 1 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 1 |
GO:0048856 | anatomical structure development | 4 (13.33%) | 0 | 0 | 0 | 2 | 0 | 1 | 1 | 0 | 0 | 0 |
GO:0009653 | anatomical structure morphogenesis | 4 (13.33%) | 0 | 0 | 0 | 2 | 0 | 1 | 1 | 0 | 0 | 0 |
GO:0032502 | developmental process | 4 (13.33%) | 0 | 0 | 0 | 2 | 0 | 1 | 1 | 0 | 0 | 0 |
GO:0050896 | response to stimulus | 4 (13.33%) | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 |
GO:0044767 | single-organism developmental process | 4 (13.33%) | 0 | 0 | 0 | 2 | 0 | 1 | 1 | 0 | 0 | 0 |
GO:0044710 | single-organism metabolic process | 4 (13.33%) | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0007154 | cell communication | 3 (10.00%) | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 0 |
GO:0016043 | cellular component organization | 3 (10.00%) | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
GO:0071840 | cellular component organization or biogenesis | 3 (10.00%) | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 |
GO:0048869 | cellular developmental process | 3 (10.00%) | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 0 |
GO:0051716 | cellular response to stimulus | 3 (10.00%) | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 0 |
GO:0007275 | multicellular organismal development | 3 (10.00%) | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 0 |
GO:0032501 | multicellular organismal process | 3 (10.00%) | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 0 |
GO:0055114 | oxidation-reduction process | 3 (10.00%) | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0048518 | positive regulation of biological process | 3 (10.00%) | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 0 |
GO:0048522 | positive regulation of cellular process | 3 (10.00%) | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 0 |
GO:0044707 | single-multicellular organism process | 3 (10.00%) | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 0 |
GO:0030154 | cell differentiation | 2 (6.67%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0016049 | cell growth | 2 (6.67%) | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0000902 | cell morphogenesis | 2 (6.67%) | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0032989 | cellular component morphogenesis | 2 (6.67%) | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0033554 | cellular response to stress | 2 (6.67%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0048589 | developmental growth | 2 (6.67%) | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0060560 | developmental growth involved in morphogenesis | 2 (6.67%) | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0009913 | epidermal cell differentiation | 2 (6.67%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0008544 | epidermis development | 2 (6.67%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0030855 | epithelial cell differentiation | 2 (6.67%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0060429 | epithelium development | 2 (6.67%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0040007 | growth | 2 (6.67%) | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0048519 | negative regulation of biological process | 2 (6.67%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 |
GO:0048513 | organ development | 2 (6.67%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0046777 | protein autophosphorylation | 2 (6.67%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 |
GO:0009628 | response to abiotic stimulus | 2 (6.67%) | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0006950 | response to stress | 2 (6.67%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0007165 | signal transduction | 2 (6.67%) | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0023052 | signaling | 2 (6.67%) | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0044700 | single organism signaling | 2 (6.67%) | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0043588 | skin development | 2 (6.67%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0048731 | system development | 2 (6.67%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0009888 | tissue development | 2 (6.67%) | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0009826 | unidimensional cell growth | 2 (6.67%) | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0010618 | aerenchyma formation | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0048646 | anatomical structure formation involved in morphogenesis | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0008219 | cell death | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0051301 | cell division | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0009932 | cell tip growth | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0022607 | cellular component assembly | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0044085 | cellular component biogenesis | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0051641 | cellular localization | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0034622 | cellular macromolecular complex assembly | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0070727 | cellular macromolecule localization | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0034613 | cellular protein localization | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0070887 | cellular response to chemical stimulus | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0071496 | cellular response to external stimulus | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0031668 | cellular response to extracellular stimulus | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0031669 | cellular response to nutrient levels | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0071407 | cellular response to organic cyclic compound | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0071310 | cellular response to organic substance | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:1901701 | cellular response to oxygen-containing compound | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0016036 | cellular response to phosphate starvation | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0071446 | cellular response to salicylic acid stimulus | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0009267 | cellular response to starvation | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0016482 | cytoplasmic transport | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0016265 | death | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0006952 | defense response | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0098542 | defense response to other organism | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0009814 | defense response, incompatible interaction | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0009790 | embryo development | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0048598 | embryonic morphogenesis | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0051234 | establishment of localization | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0051649 | establishment of localization in cell | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0045184 | establishment of protein localization | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0072594 | establishment of protein localization to organelle | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0016458 | gene silencing | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0031047 | gene silencing by RNA | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0035195 | gene silencing by miRNA | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0010052 | guard cell differentiation | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0034050 | host programmed cell death induced by symbiont | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0042743 | hydrogen peroxide metabolic process | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0006955 | immune response | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0002376 | immune system process | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0045087 | innate immune response | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0006886 | intracellular protein transport | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0035556 | intracellular signal transduction | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0046907 | intracellular transport | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0006629 | lipid metabolic process | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0051179 | localization | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0065003 | macromolecular complex assembly | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0043933 | macromolecular complex subunit organization | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0033036 | macromolecule localization | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0051704 | multi-organism process | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0051782 | negative regulation of cell division | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0048523 | negative regulation of cellular process | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0010629 | negative regulation of gene expression | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0010605 | negative regulation of macromolecule metabolic process | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0009892 | negative regulation of metabolic process | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0051170 | nuclear import | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0051169 | nuclear transport | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0006913 | nucleocytoplasmic transport | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0071702 | organic substance transport | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0009626 | plant-type hypersensitive response | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0051254 | positive regulation of RNA metabolic process | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0009891 | positive regulation of biosynthetic process | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0010647 | positive regulation of cell communication | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0010942 | positive regulation of cell death | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0045597 | positive regulation of cell differentiation | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0031328 | positive regulation of cellular biosynthetic process | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0031325 | positive regulation of cellular metabolic process | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0051094 | positive regulation of developmental process | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0010628 | positive regulation of gene expression | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:1902533 | positive regulation of intracellular signal transduction | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0010557 | positive regulation of macromolecule biosynthetic process | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0010604 | positive regulation of macromolecule metabolic process | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0009893 | positive regulation of metabolic process | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0048584 | positive regulation of response to stimulus | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0009967 | positive regulation of signal transduction | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0023056 | positive regulation of signaling | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0045893 | positive regulation of transcription, DNA-dependent | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0009791 | post-embryonic development | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0009886 | post-embryonic morphogenesis | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0016441 | posttranscriptional gene silencing | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0035194 | posttranscriptional gene silencing by RNA | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0010608 | posttranscriptional regulation of gene expression | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0012501 | programmed cell death | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0017038 | protein import | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0006606 | protein import into nucleus | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0008104 | protein localization | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0034504 | protein localization to nucleus | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0033365 | protein localization to organelle | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0032446 | protein modification by small protein conjugation | 1 (3.33%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0070647 | protein modification by small protein conjugation or removal | 1 (3.33%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0006605 | protein targeting | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0044744 | protein targeting to nucleus | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0015031 | protein transport | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0016567 | protein ubiquitination | 1 (3.33%) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0072593 | reactive oxygen species metabolic process | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0010646 | regulation of cell communication | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0010941 | regulation of cell death | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0045595 | regulation of cell differentiation | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0051302 | regulation of cell division | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0050793 | regulation of developmental process | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0040029 | regulation of gene expression, epigenetic | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0010310 | regulation of hydrogen peroxide metabolic process | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:1902531 | regulation of intracellular signal transduction | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:2000377 | regulation of reactive oxygen species metabolic process | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0048583 | regulation of response to stimulus | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0009966 | regulation of signal transduction | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0023051 | regulation of signaling | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0009607 | response to biotic stimulus | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0042221 | response to chemical | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0036293 | response to decreased oxygen levels | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0009605 | response to external stimulus | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0009991 | response to extracellular stimulus | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0001666 | response to hypoxia | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0010035 | response to inorganic substance | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0009416 | response to light stimulus | 1 (3.33%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0031667 | response to nutrient levels | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0014070 | response to organic cyclic compound | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0010033 | response to organic substance | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0051707 | response to other organism | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0006979 | response to oxidative stress | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0070482 | response to oxygen levels | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:1901700 | response to oxygen-containing compound | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0009314 | response to radiation | 1 (3.33%) | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0000302 | response to reactive oxygen species | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0009751 | response to salicylic acid | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0000304 | response to singlet oxygen | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0042594 | response to starvation | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0022618 | ribonucleoprotein complex assembly | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0022613 | ribonucleoprotein complex biogenesis | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0071826 | ribonucleoprotein complex subunit organization | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0048364 | root development | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0010053 | root epidermal cell differentiation | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0010015 | root morphogenesis | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0022622 | root system development | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0009863 | salicylic acid mediated signaling pathway | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0048367 | shoot system development | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0010016 | shoot system morphogenesis | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0044765 | single-organism transport | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0070922 | small RNA loading onto RISC | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0010374 | stomatal complex development | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0010103 | stomatal complex morphogenesis | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
GO:0010098 | suspensor development | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
GO:0009627 | systemic acquired resistance | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0009862 | systemic acquired resistance, salicylic acid mediated signaling pathway | 1 (3.33%) | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
GO:0006810 | transport | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
GO:0080159 | zygote elongation | 1 (3.33%) | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |